This grant, offered by the National Institutes of Health (NIH), aims to support high-priority research focused on the critical intersection of HIV and substance use. Its primary purpose is to foster innovative projects capable of unveiling new areas for HIV/AIDS research, alongside developing new avenues for prevention, treatment, and potential cures specifically for people who use drugs. Applicants are required to submit a detailed research plan, provide preliminary data, and clearly demonstrate the nexus between their proposed work and substance use. This opportunity is open to both individual researchers and research teams, encompassing all research areas from basic science to clinical and implementation studies. All proposals must align with the latest NIH HIV/AIDS Research Priorities.
Opportunity ID: 351847
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-25-060 |
| Funding Opportunity Title: | High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 17, 2024 |
| Last Updated Date: | Jan 17, 2024 |
| Original Closing Date for Applications: | Feb 11, 2027 |
| Current Closing Date for Applications: | Feb 11, 2027 |
| Archive Date: | Mar 19, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Public housing authorities/Indian housing authorities State governments County governments Public and State controlled institutions of higher education Small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-060.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 351847 Full Announcement-RFA-DA-25-060 -> RFA-DA-25-060-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00284451 | Jul 15, 2024 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289119 | Nov 26, 2024 | Feb 11, 2027 | View |
Package 1
Mandatory forms
351847 RR_SF424_5_0-5.0.pdf
351847 PHS398_CoverPageSupplement_5_0-5.0.pdf
351847 RR_OtherProjectInfo_1_4-1.4.pdf
351847 PerformanceSite_4_0-4.0.pdf
351847 RR_KeyPersonExpanded_4_0-4.0.pdf
351847 RR_Budget_3_0-3.0.pdf
351847 PHS398_ResearchPlan_5_0-5.0.pdf
351847 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351847 RR_SubawardBudget30_3_0-3.0.pdf
351847 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
351847 RR_SF424_5_0-5.0.pdf
351847 PHS398_CoverPageSupplement_5_0-5.0.pdf
351847 RR_OtherProjectInfo_1_4-1.4.pdf
351847 PerformanceSite_4_0-4.0.pdf
351847 RR_KeyPersonExpanded_4_0-4.0.pdf
351847 RR_Budget_3_0-3.0.pdf
351847 PHS398_ResearchPlan_5_0-5.0.pdf
351847 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351847 RR_SubawardBudget30_3_0-3.0.pdf
351847 PHS_AssignmentRequestForm_3_0-3.0.pdf